We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

improved antibody internalization and enhanced the cytotoxicity of a HER2-targeting antibody drug conjugate.

Company has Koshal & Associates as its auditors. As on 30-09-2024, the company has a total of 55.37 Crore shares outstanding.Generic Pharmasec Share Price Today is Rs. 3.11 as on 06 Jan, 2025, 03:56 ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...